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Abstract 
Introduction:  While there is an increasing volume of literature describing the health state utility 
values (HSUV) individuals with angina, heart attack or stroke, research comparing HSUVs for these 
conditions within the same study is sparse.  This hinders analysts wishing to explore the benefits of 
interventions in cardiovascular disease (CVD).  The objective of this study was to obtain EQ-5D scores 
to inform health states in CVD economic models using the same source for each health state.   
 
Methods:  EQ-5D data (N = 26,679) from individuals aged 16 to 98 years taking part in the 
Health Survey for England (2003, 2006) was used.  Regressions were employed to explore the 
significance of age, gender and history of CVD on HSUVs taking into account the number and type of 
cardiovascular condition(s) and time since event.  The predictive ability of the model was assessed 
using errors in predicted values on both the individual and the sub-group levels. 
 
Results:   Our results show HSUVs differ by age, gender, CV history, time since CV event and 
the number of concurrent CV conditions.   The regression model is reasonably accurate when 
predicting mean values for sub-groups stratified by age, CV condition and time since event, with 67% 
of predicted values within the minimal important difference for the EQ-5D index. 
   
Conclusions: The results provide a consistent basis for analysts to populate the most frequently 
defined health states (no CVD, heart attack, angina and stroke) in CVD models.  Further research is 
required to validate these results in other datasets.   
 
 
 
INTRODUCTION  
 
Policy decisions on reimbursement within health care are frequently informed by economic evaluations 
describing the cost-effectiveness of interventions in terms of the cost per quality adjusted life year.  The 
mathematical models used to generate these results are constructed to replicate the clinical pathway of 
the disease under consideration.  Models can vary from simple decision trees with just two health states 
(alive or dead) to more complex forms where each health event associated with a disease is described 
by a distinct health state. 
 
Economic models require health state utility values (HSUV) obtained from preference-based measures 
for each of the health states and the data needs to be obtained from patients whose health condition 
corresponds to the definition of the individual health state.  Depending on the health condition or the 
particular health related event, health related quality of life (HRQoL) can either improve or deteriorate 
over time.  As respondents are asked to describe their HRQoL during the immediately preceding time 
period (frequently the last seven days), long term studies are required to describe any changes over 
time.  While the evidence base describing HSUVs in different samples and settings is growing, patient 
demographics, definitions of health conditions, and the follow-up period can all differ considerably 
between studies.  The heterogeneity in study design hinders analysts when the data required to populate 
the different health states within a model is not available from a single study. 
 
Cardiovascular disease (CVD) encompasses a number of distinct but related conditions including 
angina, heart attack, stroke, transient ischaemic attack, peripheral arterial disease and peripheral 
vascular disease.  Depending on the intervention under evaluation, an economic model in CVD would 
typically include health states for a number or all of these sub-conditions and events.[1,2]  If the 
intervention is for primary prevention of CVD, individuals would enter the model with no history of 
CVD and the events modelled would be first ever CV events.[3]  Conversely, if evaluating a secondary 
intervention, individuals would enter the model with a history of one or more CV conditions and the 
events modelled would include subsequent CV events.[2]  As individuals with a history of one CV 
condition are at high risk of developing another CV condition, secondary prevention models can 
include health states for individuals with a history of a several CV conditions.  Events such as strokes 
and heart attacks are frequently fatal thus a lifetime horizon is required to quantifying the benefits 
associated with avoiding these.[4]  While CV events have a large detrimental effect on HRQoL during 
the period immediately following the event, the magnitude of the initial detriment may diminish over 
time.  Consequently CV health states are frequently defined to differentiate between the first year and 
subsequent years after the event.[1]  
 
Studies exploring the HSUVs associated with coronary heart disease and related conditions are 
generally conducted in individuals who have recently experienced just one of the CV events.  The 
inclusion criteria frequently exclude individuals who have a history of the other related conditions.  For 
example, studies exploring the effect of heart attacks may exclude individuals with a history of stroke.  
Long term data describing changes in HRQoL beyond the immediate period following a CV event are 
also scarce.  These limitations in the evidence base make it difficult to obtain HSUVs for the numerous 
health states in CVD models, many of which include co-morbidities and different histories.  
 
The objective of this study is to estimate HSUVs which can be used to populate the most frequently 
defined health states used in conventional CVD models.  Data collected during the Health Survey for 
England (HSE) provide an opportunity to explore the HRQoL reported by individuals in the general 
population.   In particular, there is sufficient detail to investigate if HSUVs differ by age, gender, type 
of cardiovascular condition (angina, heart attack or stroke), number of cardiovascular conditions and 
time since CV event.  While an analysis of US data showed differences between the HSUVs for angina, 
heart attack and stroke,[5] to our knowledge, this is the first publication which provides all these data 
from a single source for a UK population and also shows a change in HSUVs over time.   
 
 
METHODS 
 
Health Survey for England 
The Health Survey for England (HSE) is an annual nationwide survey which uses a random sample of 
the population living in private households in England.[6-7]  The surveys conducted in 2003 (N = 
18,553) and 2006 (N = 21,399) focused on CVD and included questions on the respondent’s history of 
angina, heart attack or stroke.  The positive responses (i.e. “yes”) to the questions “doctor diagnosed 
angina”; “doctor diagnosed heart attack” or “doctor diagnosed stroke” were used to identify individuals 
who had a history of CVD.  Given a doctor’s diagnosis of CVD, the positive responses to the questions 
“angina in the last year”, “heart attack in the last year”, “stroke in the last year”, were used to identify 
individuals who had experienced a CV event in the previous 12 months.  These responses were then 
used together with positive responses to the questions “ever had angina”, “ever had a heart attack” or 
“ever had a stroke”, and a doctor’s diagnosis, to identify individuals who had a history of a CV 
condition prior to the previous 12 months.   
 
These data allow us to estimate EQ-5D scores for health states defined in both primary prevention 
models (no history of CVD; angina, heart attack or stroke within the previous 12 months given a 
history of just one CV condition; angina, heart attack or stroke but no event within the previous 12 
months given a history of just one CV condition), and secondary prevention models (given a history of 
more than one CV condition, angina, heart attack or stroke within the previous 12 months given a 
history of more than one CV condition; angina, heart attack or stroke but no event within the previous 
12 months given a history of more than one CV condition). 
 
 
The EQ-5D preference-based instrument 
A random sample of the HSE respondents were asked to complete the EuroQol questionnaire (N = 
26,679).[8]  This is a generic preference-based measure of health commonly used to obtain health state 
valuations.  It has five health dimensions with three levels each describing a total of 243 health states.  
Patients complete a one page questionnaire to assign them to a health state and the preference-weighted 
algorithm is then applied to obtain the corresponding EQ-5D index score.  The weights for the EQ-5D 
preference-based index used in the current study were obtained (based on time trade off valuations) 
from the UK general public.[9]  The index covers the range -0.594 to 1 whereby -0.594 represents the 
most severe impairment on all five dimensions and 1 represents no problems on any dimension.  The 
minimal important difference (MID), defined as the smallest difference in score which patients 
perceive as beneficial, is |0.074|.[10]  The EQ-5D has to be completed by patients with different health 
conditions in order to obtain mean values for each condition.   
   
 
Statistical methods 
Standard descriptive techniques were used (mean, range, standard error) and the significance of any 
potential difference in mean EQ-5D values for either gender, presence of CVD, type of CV condition, 
or time since event was assessed using independent t-tests (p = 0.05).  The EQ-5D index was regressed 
onto age, sex and history of CVD using ordinary least square (OLS) techniques.  The model is of the 
form:  
 
 EQ = b + b1xi + b2yi + b3zi + ε whereby 
 
EQ represents the EQ-5D preference-based index, i represents individual respondents, b represents the 
vector of unknown variables, x represents the vector of demographs (age and sex), y represents the 
vector of health conditions (given a history of just one CV condition: angina within the previous year, 
heart attack within the previous year, stroke within the previous year, angina prior to the previous year, 
heart attack prior to the previous year, stroke prior to the previous year; given a history of greater than 
one CV condition: angina within the previous year, heart attack within the previous year, stroke within 
the previous year, angina prior to the previous year, heart attack prior to the previous year, stroke prior 
to the previous year), z represents the vector of cross-products and ε represents the stochastic error term 
of the regression (the residual).   
 
History of CVD and sex were entered as dummy variables with zero representing no history of a CV 
condition and female respectively.  As no history of CVD was the reference category a negative 
coefficient was expected for the regression coefficients for the various health conditions.  Based on 
evidence in the literature suggesting males have a higher QoL than females, the coefficient for sex was 
expected to be positive.   
 
Analyses were performed in SPSS (v12) and the models were constructed in STATA (v6).  Models 
were compared using the variance explained by the model (adj. R2) and standard descriptive statistics 
(mean, sd, range) of the individual predicted values.  The predictive ability of the model was assessed 
using the mean error (ME), the mean absolute error (MAE), the root mean squared error (RMSE) and 
the proportion of values within the MID.[10]  As we were interested in estimating mean cohort values 
to populate health states within a model as opposed to individual patient level values, the model was 
also assessed in terms of ability to predict mean values for sub-groups (age, history of CV condition(s) 
and time since event). 
 
 
RESULTS 
The mean age of all participants with EQ-5D data (n = 26,679) is 48 years (range 16-98) and 44% 
(11,837) are male.  The mean age of respondents (n = 1,599) who report a doctor’s diagnosis of CVD is 
68 years (range 19-97) and 56% (897/1599) are male.  The prevalence of CVD is low below the age of 
50 years (<1%) compared to prevalence in the older group (14%), and is higher in males than females 
of the same age reflecting the increased risks in these cohorts.  The mean duration of time since a 
doctor’s diagnosis of CVD is 10 years (median: 10 years).   
 
The data were sub-grouped according to type and history of CV conditions: just angina, just heart 
attack, just stroke, or any combination of these (Figure 1).   Of the 1,599 with a doctor’s diagnosis of 
CVD, 963 (57% male) have a history of angina, 652 (67% male) have a history of a heart attack and 
522 have a history of a stroke (49% male).  63 (53% male) have a history of both angina and stroke, 
323 (72% male) have a history of both angina and heart attack, 32 (59% male) have a history of both a 
heart attack and a stroke, and 60 (72% male) have a history of all three conditions.  643/1599 (56% 
male) of individuals with a history of CVD report they had at least one event in the previous 12 
months.  For angina, the majority (516/963) reported an event within the previous 12 months, but for 
heart attack and stroke this was 94/428 and 67/585 respectively.   
 
 
INSERT  Figure 1: Number of respondents with a doctor’s diagnosis of CVD sub-grouped by 
history of condition and time since last event 
 
 
Health state utility values: univariate results  
The EQ-5D scores cover the full range (mean: 0.860; range: -0.59 to 1) and 58% (15409/26679) score 
the maximum value of 1.  There is a significant difference (Table 1) in the mean EQ-5D scores for 
males compared with females (males EQ-5D = 0.87, females EQ-5D = 0.850; p <0.001).  There is also 
a significant difference (p <0.001) in the mean EQ-5D scores for those with no history of CVD (EQ-5D 
= 0.870) compared with those with a history of CVD (EQ-5D = 0.650), and in those who reported an 
event within the previous 12 month period (EQ-5D = 0.589) compared with those who experienced an 
event prior to this (EQ-5D = 0.716; p <0.001).  There is a trend in the data (Figure 2) suggesting CVD 
has a larger detriment on HSUVs for younger aged cohorts when compared to individuals with no 
history of CVD, particularly for individuals who reported an event within the previous 12 months.     
 
 
INSERT     Table 1: Mean EQ-5D scores sub-grouped by type and number of CV conditions 
 
 
There is a significant difference in the mean HSUV for individuals with a history of one CV condition 
(N = 1,121; EQ-5D = 0.691) compared with those with a history of more than one CV condition (N = 
478; EQ-5D = 0.604, p <0.001).  The mean HSUVs for individuals with a history of just angina (n = 
517), just heart attack (n = 237) or just stroke (n = 367) are 0.692, 0.740 and 0.660 respectively.  For 
individuals with a history of more than one condition, the mean HSUVs for individuals with angina (n 
= 446), heart attack (n = 415) and stroke (n = 155) are 0.609, 0.605 and 0.562 respectively.   
 
When sub-grouping according to time since the last CV event, there is a significant difference in the 
HSUVs for individuals who report at least one CV event in the previous 12 months (n = 643, mean EQ-
5D = 0.590) compared to those who report a CV event prior to this (n=956, mean EQ-5D = 0.716; p 
<0.001).   For individuals who reported just one event in the previous 12 months (N=610; EQ-5D = 
0.597), there is a significant difference in the mean HSUVs for individuals with a history of just one 
CV condition (N = 378; EQ-5D = 0.626) compared with those with a history of more than one CV 
condition (N = 232; EQ-5D = 0.550, p <0.005).   
 
 INSERT      Figure 2: Mean HSUVs sub-grouped by time since CV event  
 
 
Exploring the relationship between HSUVs and clinical events 
The results of the OLS multivariate regression between the EQ-5D preference-based index, history of 
CVD (either angina, heart attack or stroke given a history of just one CV condition; and either angina, 
heart attack or stroke given a history of more than one CV condition) and time since the most recent 
event (either within the previous 12 months or prior to the previous 12 months) is provided in Table 2.    
 
 
INSERT  Table 2:  Results of the OLS multivariate regression showing the relationship 
between the EQ-5D preference-based index, patient characteristics, type and time of reported CV 
events 
 
 
With regard to the effect of the clinical events, the coefficients are significant and negative for all 
events reported during the previous 12 months, illustrating the large detrimental effect on QoL during 
the first 12 months after an event.  All coefficients for the health states describing no event reported 
within the previous 12 months are also significant and negative, showing there is a long term 
detrimental effect beyond the initial period after an event.  The coefficients for the health states for 
individuals with greater than one CV condition are also larger in magnitude than the corresponding 
data for individuals with a history of just one CV condition demonstrating the additional detriment 
associated with a history of more than one CV condition.  For individuals with a history of just one CV 
condition, angina has the largest detrimental effect during the first 12 months (-0.173), heart attack has 
the smallest effect (-0.018), and for individuals with a history of more than one CV condition, angina 
has the largest detriment on QoL (-0.308).   
 
Looking at the predicted HSUVs for the full dataset, the scores (Table 2) range from 0.035 to 0.962 
(mean = 0.873) compared to the observed range of -0.59 to 1.00 (mean = 0.860).  With a MAE of 0.145 
and RMSE of 0.215, just 31% of values are predicted within the MID.    However, as the results are to 
be used to populate a cohort level model, we are more interested in the model’s ability to predict mean 
health state values accurately.  When sub-grouping by one year age bands (n = 901) and by 10 year age 
bands (Table 3) taking into account history of CVD disease (n = 48), the predicted values have a ME 
(MAE, RMSE) of 0.037 (0.151, 0.218) and 0.001 (0.057, 0.072) respectively with 41% and 67% of 
values correct to within the MID (|0.074|).  Similarly, when predicting the mean EQ-5D scores for the 
sub-groups split by health condition and time since event (Table 4), the model predicts 12/13) of mean 
values within the MID.[10] 
 
 
INSERT:  Table 3: Observed and predicted mean EQ-5D scores for the 13 health states defined 
by type of CV history and time since event 
 
 
INSERT:  Table 4: Errors in predicted values for sub-groups of data 
 
 
DISCUSSION 
This study is the first to use a single data source (N = 26,679) in the UK to obtain HSUVs for health 
states most frequently used in CVD economic models, taking into account both the time since the most 
recent event and history of CV condition(s).  Our results show there is a significant difference  (p 
<0.05) in the EQ-5D scores according to age, sex, CV history, time since CV event, and both the type 
and number of CV condition(s).   The regression model will enable analysts to populate health states in 
economic models assessing primary prevention interventions using a baseline quality of life adjusted 
for age and sex from individuals with no history of CVD, and health states in economic models 
assessing secondary prevention interventions where individuals enter the model with a reduction in 
quality of life associated with the long term effects of CVD.   We provide additional information to 
enable analysts to sample from these data in probabilistic analyses (Appendix 1). 
 
There are, however, limitations with the dataset which may have implications with regard to the 
generalisability of the results.  We use the self-reported responses to a doctor’s diagnosis of CV 
disease, time of event (i.e. within the previous 12 months or prior to this), and the number and type of 
CV condition.  This will inevitably introduce a degree of uncertainty in the results generated.  In 
addition, HSE samples exclude individuals in nursing homes or hospitals.  This may introduce a bias as 
individuals in private households are likely to be more independent, and the time since the last event is 
likely to be longer when compared to counterparts in residential homes or hospitals.   
 
Our data show HSUVs for individuals with a history of angina or heart attack range from 0.56 to 0.77 
or 0.53 to 0.74 respectively depending on the time since previous event and the history of other CV 
conditions.  These data are comparable with values reported in the literature: EQ-5D = 0.50 for patients 
(n = 188) with refractory angina,[11] EQ-5D = 0.67 at baseline and 0.74 at 12 months for unstable 
angina/non ST-segment elevation myocardial infarction,[12] and EQ-5D = 0.683 and 0.718 
respectively at six weeks and one year after discharge from hospital in patients experiencing a heart 
attack.[13]  The existing evidence describing HSUVs for stroke are more diverse.  One study reports 
values ranging from EQ-5D = 0.33 for patients (n=43) on discharge to a care home to EQ-5D = 0.60 
for patients (n = 50) 12 months after discharge to their own home.[14]  A second study reports mean 
values ranging from EQ-5D = 0.5907 at 6 weeks after stroke to EQ-5D = 0.6510 at 12 months after 
discharge (n = 153) for patients randomised to a stroke unit (n = 52), a stroke team (n = 152) or 
domiciliary care (n = 153).[15]  However, as observed in our data (EQ-5D range: 0.417 (CI: 0.567, 
0.715) to 0.668 (CI: 0.632, 0.704), there was a large variation (sd > 0.30) in the HSUVs in both studies. 
 
The data were sub-grouped according to history of different CV conditions: just angina, just heart 
attack, just stroke, or a combination of these (Figure 2).   While heart attacks and strokes are distinct 
time constrained medical events, angina is an ongoing condition characterised by periods of pain in the 
chest area.  The condition encompasses a wide spectrum and severity ranges from mild discomfort on 
exercising to severe pain requiring urgent medical attention.  As the majority of CV models do not 
define different health states to differentiate between the different classes of angina, for the purpose of 
this exercise, we identified individuals with a history of angina by using the positive response to a 
doctor’s diagnosis of angina.  While this ensures we cover the full spectrum of the condition weighted 
by severity prevalence in the general population, this does introduce some ambiguity by what is meant 
by “experienced angina within the previous 12 months”.     
 
It is common for EQ-5D index scores to exhibit a ceiling effect, with a significant number of 
respondents rating themselves as being in full health, i.e. responses of 11111 on the original 
questionnaire give a preference-based tariff score of 1.  To account for the non-linear distribution of the 
data, we explored Tobit and censored least absolute deviation (CLAD) models with upper censoring at 
1.0 (results not shown).   However, we found the OLS model we report was more accurate in predicting 
HSUVs than either the Tobit or CLAD models obtained.   
 
 
CONCLUSION 
While there are limitations with the sample used in the current study, the results show HSUVs differ by 
age, sex, type of CV condition, time since CV event and the number of concurrent CV conditions.  The 
results of the regressions will enable analysts to populate the most frequently defined health states in 
CVD models.     
 
ACKNOWLEDGEMENT 
We are grateful to Health Survey for England for allowing us access to the data used in this study. The 
research was based on the Health Survey for England, 2003 and the Health Survey for England 2006, 
produced by the Joint Health Surveys Unit of Social and Community Planning and University College 
London, sponsored by the Department of Health, and supplied by the UK Data Archive. The data are 
Crown copyright. 
REFERENCES 
1.   Ara R, Pandor A, Stevens J, Rees A, Rafia R. Early high-dose lipid-lowering therapy to avoid 
cardiac events: a systematic review and economic evaluation. Health Technol Assess. 2009 
Jul;13(34):1-118. 
2.  Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Rees A, Wilkinson A, 
Durrington P, Chilcott J. Cost effectiveness of ezetimibe in patients with cardiovascular disease and 
statin intolerance or contraindications: a Markov model. Am J Cardiovasc Drugs. 2008;8(6):419-27. 
3.  Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N. A 
systematic review and economic evaluation of statins for the prevention of coronary events. Health 
Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review. 
4.  National Institute of Health and Clinical Excellence. Guide to the methods of Technology 
Appraisal.  2008. 
5.  Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in 
the United States. Med Decis Making 2005;26:410-420. 
6.  Joint Health Surveys Unit of Social and Community Planning Research and University 
College London, Health Survey for England, 2003 [computer file]. 3rd Edition. Colchester, Essex: UK 
Data Archive [distributor], 2005. SN: 5098.  
7.  Joint Health Surveys Unit of Social and Community Planning Research and University 
College London, Health Survey for England, 2006 [computer file]. 3rd Edition. Colchester, Essex: UK 
Data Archive [distributor], 2008. SN: 5809. 
8.  EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. 
Health Policy.  1990;16:199–208. 
9.  Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general 
population study. Health Econ. 1996;5(2):141–54. 
10.   Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state 
utility measures: EQ-5D and SF-6D Quality of Life Research (2005) 14:1523–1532.   
11.  Campbell HE, Tait S, Buxton MJ, Sharples LD, Cain N, Schofield PM, Wallwork J. A UK 
trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued 
medical therapy for treatment of refractory angina pectoris European Journal of Cardio-thoracic 
Surgery 20 (2001) 312:318. 
12.  Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KAA  and RITA-3 Trial 
Investigators. Health-related quality of life after interventional or conservative strategy in patients with 
unstable angina or non–ST-segment elevation myocardial infarction: One-year results of the third 
randomized intervention trial of unstable angina (RITA-3) J. Am. Coll. Cardiol. 2005;45;221-228. 
13. Lacey  EA, Walters SJ. Continuing inequality: gender and social class influences on self 
perceived health after a heart attack J. Epidemiol. Community Health 2003;57;622-627. 
14. Leeds L, Meara J, Hobson P. The impact of discharge to a care home on longer term stroke 
outcomes. Clinical Rehabilitation 2004; 18: 924-928. 
15. Patel A, Knapp M, Perez I, Evans A, Kalra L, Alternative Strategies for Stroke Care Cost-
Effectiveness and Cost-Utility Analyses From a Prospective Randomized Controlled Trial Stroke. 
2004;35:196-204. 
 
 
Figure 1: Number of respondents with a doctor’s diagnosis of CVD (N = 1,599) sub-grouped 
by history of condition and time since last event 
 
 
 
 
 
Heart 
Attack 
N=645 
N=66 
 
Angina 
N=517 
n1=271 
n2=246 
Heart Attack 
N=237 
n1=31 
n2=206 
Stroke 
N=367 
n1=76 
n2=291 
N=63 
n1=34 
n2=29 
N=32 
n1=3 
n2=29 
N=323 
n1=187 
n2=136 
 
N=60 
n1=41 
n2=19 
eart Attack 
N=652 
n1=67 
n2=585 
 
Stroke 
N=522 
n1=94 
n2=428 
N = number of individuals with a doctors diagnosis of the condition at any time 
n1 = number of individuals experiencing an event in the previous 12 months 
n2 = number of individuals not experiencing an event in the previous 12 months 
Angina 
N=963 
n1=516 
n2=447 
Figure 2a: Mean EQ-5D scores sub-grouped by history of CVD and time since CV  
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Figure 2b: Mean EQ-5D scores sub-grouped by history of CVD and number of CV conditions 
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 Table 1: Mean EQ-5D scores sub-grouped by type and number of CV conditions 1 
Sub-group  EQ-
5D 
  
 N mean LCI UCI 
p-
value 
Male  11,837 0.8720 0.8680 0.8759 <0.001 
Female 14,842 0.8496 0.8459 0.8534  
No history of CVD 25,080 0.8719 0.8692 0.8746 <0.001 
History of any CVD (t =  ever) 1,599 0.6653 0.6499 0.6806  
History of CVD and CV event < 12 months 640 0.5894 0.5641 0.6147 <0.001 
History of CVD and no CV event < 12 months 956 0.7161 0.6975 0.7346  
Sub-grouped by the number of CV conditions and time since event 
History of just one CV condition 1,121 0.6909 0.6734 0.7083 <0.001 
History of > one CV condition 478 0.6040 0.5737 0.6255  
History of just one CV condition, and a CV event < 12 months 378 0.6258 0.5941 0.6576 <0.005 
History of > one CV condition, and a CV event < 12 months 232 0.5500 0.5081 0.5920  
Individuals with a history of just one CV condition, sub-grouped by condition 
(as defined by health states in a primary prevention model) 
History of just angina, angina < 12 months 271 0.6148 0.5770 0.6526 <0.001 
History of just angina, no angina < 12 months 246 0.7748 0.7451 0.8046  
History of just heart attack, heart attack < 12 months 31 0.7213 0.6303 0.8123 0.700 
History of just heart attack, no heart attack < 12 months 206 0.7418 0.7033 0.7803  
History of just stroke, stroke < 12 months 76 0.6262 0.5515 0.7010 0.301 
History of just stroke, no stroke < 12 months 291 0.6684 0.6323 0.7044  
Individuals with a history of more than one CV condition, sub-grouped by condition 
(as defined by health states in a secondary prevention model) 
History of angina + other CV condition(s), angina < 12 months  213 0.5563 0.5127 0.5999 <0.001 
History of angina + other condition(s), angina < 12 months, no 
event < 12 months  
184 0.7149 0.6710 0.7589  
History of heart attack + other condition(s), heart attack < 12 
months 
11 0.5250 0.3038 0.7462 0.113 
History of heart attack + other condition(s), no event < 12 
months 
184 0.6847 0.6378 0.7316  
History of stroke + other condition(s), stroke < 12 months 8 0.4170 0.5668 0.7146 0.072 
History of stroke + other condition(s), no event < 12 months 77 0.6407 0.1032 0.7308  
Comparing the effect on HSUVs for events within the last 12 months, sub-grouped by history of number of CV 
conditions 
History of just angina, angina < 12 months 213 0.5563 0.5127 0.5999 <0.05 
History of angina + other CV condition(s), angina < 12 months 271 0.6148 0.5770 0.6526  
History just heart attack, heart attack < 12 months  11 0.5250 0.3038 0.7462 <0.005 
History heart attack + other CV condition(s), heart attack < 12 
months  
237 0.7391 0.7038 0.7744  
History just stroke, stroke < 12 months 76 0.6262 0.5515 0.7010 0.170 
History stroke + other CV condition(s), stroke < 12 months 155 0.5618 0.5082 0.6155  
 2 
 3 
 4 
 5 
 6 
Table 2:  Results of the models exploring the relationship between the EQ-5D preference-based index, 7 
patient characteristics, type and time of reported CV events 8 
 OLS 
 Beta se Sig 
Male 0.0246479 0.0027 ** 
Age -0.0008459 0.0004 * 
Age2 -0.0000224 0.0000 ** 
Age*CVD -0.0001961 0.0003 a 
History of just angina, angina < 12 months -0.1726541 0.0268 ** 
History of just angina, no angina < 12 months -0.0184099 0.0271 b 
History of just heart attack, heart attack < 12 months -0.0864901 0.0446 *  
History of just heart attack, no heart attack < 12 months -0.0595563 0.0274 *  
History of just stroke, stroke < 12 months -0.1609510 0.0336 ** 
History of just stroke, no stroke < 12 months -0.1255921 0.0262 ** 
History of angina + other CV condition(s), angina < 12 months  -0.2370623 0.0278 ** 
History of angina + other condition(s), no event < 12 months  -0.0801248 0.0300 ** 
History of heart attack + other condition(s), heart attack < 12 months -0.2560437 0.0689 ** 
History of heart attack + other condition(s), no event < 12 months~    
History of stroke + other condition(s), stroke < 12 months -0.3324484 0.0805 ** 
History of stroke + other condition(s), no event < 12 months -0.0634942 0.0306 * 
Constant 0.9569784 0.0089 ** 
min 0.0353 
 
 
mean 0.8727 
 
 
max 0.9624 
 
 
Adj. R2 0.2138   
Errors in predicted values for individual level patient (n = 26,679) responses 
ME 0.0131   
MAE 0.1446   
RMSE 0.2151   
|0.074|# 31%   
|0.05| 15%   
Significance: * p <0.05; ** p<0.01,  a p = 0.574, b p = 0.497, cp = 0.639; # = MID, ~ as history of angina 9 
+ other condition(s), no event < 12 months. See Appendix 1 for variance covariance matrix. 10 
 11 
 12 
 13 
Table 3:  Errors in predicted values for sub-groups of data 14 
 1 year age bands (n = 901) 
10 year age bands and history 
of CV condition (s) (n = 48) 
ME 0.0274 0.0014 
MAE 0.1508 0.0571 
RMSE 0.2184 0.0722 
|0.074|# 41% 67% 
|0.05| 32% 46% 
# = MID 15 
 16 
 17 
 18 
Table 4: Observed and predicted mean EQ-5D scores for the 13 health states defined by type of CV history and 19 
time since event  20 
 n Observed Predicted Error 
No history of CVD 25,080 0.872 0.878 0.007 
history of just angina, angina < 12 months 271 0.615 0.621 0.006 
history of just angina, no angina < 12 months 246 0.775 0.778 0.003 
history of just heart attack, heart attack < 12 months 31 0.721 0.724 0.003 
history of just heart attack, no heart attack < 12 months 206 0.742 0.745 0.004 
history of just stroke, stroke < 12 months 76 0.626 0.632 0.006 
history of just stroke, no stroke < 12 months 291 0.668 0.673 0.005 
history of angina + other CV condition(s), angina < 12 months  213 0.556 0.559 0.003 
history of angina + other condition(s), angina < 12 months, no event < 12 months  184 0.715 0.714 -0.001 
history of heart attack + other condition(s), heart attack < 12 months 11 0.525 0.529 0.004 
history of heart attack + other condition(s), no event < 12 months 184 0.685 0.715 0.031 
history of stroke + other condition(s), stroke < 12 months 8 0.417 0.419 0.002 
history of stroke + other condition(s), no event < 12 months 77 0.641 0.723 0.082 
     
MAE    0.012 
RMSE    0.025 
<|0.074|   12/13 92% 
<|0.05|   12/13 92% 
# = MID 21 
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Appendix: Var-Covar Matrix used for generating samples from the regression 26 
 sex age age2 agecv rjang nrjang rjhrt nrjhrt rjstr nrjstr rmang cnrmamh 
Sex 0.0000070                       
Age 0.0000000 0.0000002           
Age^2 0.0000000 0.0000000 0.0000000          
Age*CVD 0.0000000 0.0000000 0.0000000 0.0000001         
The next six rows relate to health states with a history of just one CV condition 
rjang 0.0000001 -0.0000014 0.0000000 -0.0000081 0.0007190        
nrjang -0.0000008 -0.0000014 0.0000000 -0.0000081 0.0005480 0.0007340       
rjhrt -0.0000018 -0.0000014 0.0000000 -0.0000078 0.0005290 0.0005280 0.0019920      
nrjhrt -0.0000017 -0.0000014 0.0000000 -0.0000080 0.0005390 0.0005380 0.0005190 0.0007520     
rjstr 0.0000003 -0.0000012 0.0000000 -0.0000080 0.0005370 0.0005360 0.0005170 0.0005270 0.0011300    
nrjstr 0.0000001 -0.0000013 0.0000000 -0.0000080 0.0005380 0.0005370 0.0005180 0.0005280 0.0005260 0.0006850   
The next five rows relate to health states with a history of > one CV condition 
rmang -0.0000012 -0.0000014 0.0000000 -0.0000082 0.0005520 0.0005510 0.0005320 0.0005420 0.0005400 0.0005410 0.0007700  
nrmang -0.0000021 -0.0000014 0.0000000 -0.0000082 0.0005550 0.0005540 0.0005340 0.0005440 0.0005420 0.0005430 0.0005570 0.0008980 
rmhrt 0.0000006 -0.0000013 0.0000000 -0.0000083 0.0005600 0.0005590 0.0005390 0.0005490 0.0005480 0.0005490 0.0005630 0.0005650 
rmstr -0.0000023 -0.0000010 0.0000000 -0.0000093 0.0006330 0.0006310 0.0006090 0.0006210 0.0006190 0.0006200 0.0006360 0.0006390 
nrmstr 0.0000012 0.0000000 0.0000000 -0.0000002 0.0000130 0.0000120 0.0000120 0.0000120 0.0000120 0.0000120 0.0000120 -0.0003260 
Constant -0.0000025 -0.0000032 0.0000000 -0.0000004 0.0000240 0.0000240 0.0000260 0.0000250 0.0000200 0.0000230 0.0000250 0.0000260 
History of just one CV condition: Rjang = history of just angina, angina < 12 months, nrjang = history of just 27 
angina, no angina < 12 months, rjhrt = history of just heart attack, heart attack < 12 months, nrjhrt = history of 28 
just heart attack, no heart attack < 12 months, rjstr = history of just stroke, stroke < 12 months, nrjstr = history 29 
of just stroke, no stroke < 12 months 30 
History of > one CV condition:  rmang = history of angina + other CV condition(s), angina < 12 months, 31 
nrmang = history of angina + other condition(s), angina < 12 months, no event < 12 months, rmhrt = history of 32 
heart attack + other condition(s), heart attack < 12 months, rmstr = history of stroke + other condition(s), stroke 33 
< 12 months, nrmstr = history of stroke + other condition(s), no event < 12 months 34 
